Authorised Prescriber and peptides in Australia
Short answer: Authorised Prescriber is a TGA scheme granting a specific doctor ongoing approval to supply a specific unapproved medicine to a class of patients. For compounded peptides, SAS Category B is the far more common lawful route.
'Authorised prescriber' gets used loosely in peptide marketing. Here's what the TGA scheme actually is, how it differs from SAS-B and personal importation, and which pathway a legitimate Australian prescriber will use for your peptide.
The three lawful access pathways
1. ARTG-registered medicine — approved for supply in Australia, prescribed normally (e.g. semaglutide, tirzepatide). 2. Special Access Scheme Category B — patient-by-patient access to an unapproved medicine, lodged by the prescriber. This is the usual route for compounded peptides. 3. Authorised Prescriber — practitioner-level authorisation for a specified unapproved product and patient class, with periodic TGA reporting. Anything outside these is not an 'alternative pathway'; it's unlawful supply.
Why SAS-B is the norm for peptides
Compounded peptide therapy is highly individualised: product, dose and indication vary per patient, which fits SAS-B's per-patient model. Authorised Prescriber authorisation is granted for a defined product and indication and requires ethics committee or specialist college endorsement, so it's better suited to a narrow, stable use case than to individualised compounding.
What this means for you as a patient
You don't need to choose a pathway — your doctor does, and they'll tell you which applies. What you should confirm is that a named AHPRA-registered Australian doctor is prescribing, that the lawful pathway is documented, and that a TGA-licensed Australian compounding pharmacy is dispensing.
FAQs
- What is a TGA Authorised Prescriber?
- Authorised Prescriber (AP) is a TGA scheme that lets a specified medical practitioner supply a specified unapproved medicine to a class of patients under their care, without notifying the TGA for each individual patient. Authorisation is granted per practitioner, per product, per indication.
- What is the difference between Authorised Prescriber and SAS-B?
- SAS Category B is patient-by-patient: the doctor lodges a notification or application for each person. Authorised Prescriber is granted up front for a class of patients, with periodic reporting to the TGA instead of per-patient lodgement. Both are lawful routes to an unapproved medicine.
- Are peptides prescribed under Authorised Prescriber in Australia?
- Occasionally, but SAS-B is the common route for compounded peptides such as BPC-157, CJC-1295 and ipamorelin. AP requires endorsement by a human research ethics committee or a specialist college and is tied to a defined product and indication, which suits established specialty use more than individualised compounding.
- Which pathway will my doctor use?
- Most PeptideDoctorAU prescriptions for unapproved peptides go through SAS-B. ARTG-registered medicines such as semaglutide and tirzepatide need neither pathway — they're prescribed normally.
- Can I import peptides myself under the personal importation scheme?
- The personal importation scheme has strict limits and does not make unlawful goods lawful. Many peptides sold offshore as 'research chemicals' are Schedule 4 substances; importing them without a valid prescription can breach the Customs Act and the Poisons Standard, and shipments are routinely seized.
- Does Authorised Prescriber status make a clinic more legitimate?
- Not by itself. What matters is a named AHPRA-registered doctor, a genuine assessment, a lawful supply pathway and an Australian licensed pharmacy. A clinic advertising 'authorised prescriber' without naming the doctor or the product is marketing, not compliance.
Related reading
Medically reviewed by the PeptideDoctorAU Medical Review Panel — last reviewed 29 May 2026. See the panel.
Start lawfully — $99 telehealth consult
Free 5-minute pre-qualification. If suitable, you'll be matched with an AHPRA-registered Australian doctor — TGA SAS-B prescribing, Australian-compounded vial.
Start free assessment